The Case of the Unknown Protein
After a trip to the grocery store, you may find yourself with seemingly unlimited options on what to eat, but ten days later, you might be looking at bare shelves and trying to decide between ramen noodles or the slightly grayish looking leftovers from who knows when.
Lawrence David, Anthony Sung receive Damon Runyon-Rachleff Innovation Award
Lawrence David and collaborator Anthony Sung (Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy) have been awarded a Stage 2 Damon Runyon-Rachleff Innovation Award.
Weapon of Mass Congestion: Protection from Influenza Virus through Gene Control
The Defense Advanced Research Projects Agency (DARPA) is hoping to give people a different kind of superpower: protection from potentially lethal health threats
Accessing the Gut-Brain Axis
Xiling Shen, Ph.D., received $400,000 from the Chan Zuckerberg Initiative (CZI) to become a part of CZI’s Seed Networks for the Human Cell Atlas, along with 37 other collaborative science teams.
Sweet Adaptation
Giant Axonal Neuropathy (GAN), has fewer than 100 known cases, which makes research – and therefore treatment options – scarce.
Shah Named Associate Dean and Director of Duke Precision Genomics Collaboratory
Svati Shah, MD, MHS, has been named Associate Dean of Genomics and Director of the Duke Precision Genomics Collaboratory. The collaboratory is a new coordinating center that will serve as the nexus for genetics and genomics activities in the School of Medicine. As director, Dr. Shah will coordinate efforts among institutes, centers and departments in all areas of genetics and genomics, ranging from fundamental basic science to clinical genomics and precision medicine.
Defending Against Kidney Cell Carcinomas
Diet fads that influence consumers to deprive their bodies of certain foods, such as the Atkins low-carb diet program, have been around for decades.
Guts and Glory: David Lab Studies Gut Microbiome
Like fingerprints, everyone has a unique gut microbiome.
Get FOCUSed
The goals of this FOCUS cluster are to explore genome sciences in various contexts as well as explore the biomedical, biological, historical, technical, and ethical implications of genomic advances and the questions that these advances pose for understanding the past and contemplating the future of biomedicine.
Using Supercomputers to Checkmate Cancer
Duke PhD student Marcel Frenkel knows this problem well, as he watched his mom’s pancreatic cancer develop resistance to her therapies and pass away in 2015.